Nav: Home

Immune cells derived from specialised progenitors

May 05, 2017

Dendritic cells are gatekeepers of Immunity and are crucial for the detection and initiation of Immunity against pathogens and foreign substances. Up to now dendritic cell subtypes were thought to develop from one common progenitor. Now, in a joint effort, researchers from A*STAR Singapore Immunology Network, LIMES-Institute and cluster of excellence ImmunoSensation from University of Bonn and the German Center for Neurodegenerative Diseases were able to show with single cell resolution that this important component of the human immune system develops from specialized progenitors. These findings are now published in Science and have implications for the development and optimization of vaccines.

"Our blood is more than just red blood cells, which are important for oxygen transport", Dr. Andreas Schlitzer of the University of Bonn states. "It's full of a variety of Immune cells which are crucial for the defence against pathogens such as bacteria or viruses". Researchers have been dissecting the blood immune cell compartment for a long time. Human dendritic cells in the blood are an important interface between the innate and the adaptive branch of the immune system. Thereby these results constitute an important step in understanding the role of this immune cell subtype during the regulation of human immune responses.

How are these processes regulated?

"Up to know assessing the transcriptional regulation of single human dendritic cells was extremely difficult", Dr. Schlitzer reports. However now the research teams from Singapore and the University of Bonn were able to analyse these processes with a combination of single cell transcriptomics, Mass Cytometry and sophisticated high-dimensional flow cytometry, which allowed unprecedented detail to fully understand the development of these immune cells.

The research team, led by Dr Florent Ginhoux from A*STAR's Singapore Immunology Network (SigN) in collaboration with Prof. Dr. Joachim Schultze, Dr. Andreas Schlitzer and Dr. Marc Beyer from the Life & Medical Sciences Institute (LIMES) of the University of Bonn and the German Center for Neurodegenerative Diseases were now able to analyse the regulation of human dendritic cell development and functional specialization with single cell resolution in the human blood and bone marrow.

Mapping the complete developmental cycle of human dendritic cells

During the analysis of the complete developmental cycle of these dendritic cells the researcher made a remarkable finding. Previously it was thought that dendritic cell subtypes derive from one common progenitor, however this dogma has been overthrown by these recent data. Here, the researchers could show that dendritic cells, rather than developing from one common progenitor, are developing from subtype specialised progenitors which find their subtype identity already very early during their development in the human bone marrow.

These findings provide the basis for a better and more detailed understanding of the regulation of human immune response and are important for the development of new and more effective vaccinations against e.g. infectious diseases.
-end-
Publication: Mapping the human DC lineage through the integration of high-dimensional techniques, Science, DOI: 10.1126/science.aag3009

Contact:

Dr. Andreas Schlitzer
LIMES-Institute
University of Bonn
Tel. +49-228-7362847
E-mail: andreas.schlitzer@uni-bonn.de

PD Dr. Marc Beyer
LIMES-Institute
University of Bonn
German Center for Neurodegenerative Diseases (DZNE)
Tel. +49-228-43302565
E-mail: marc.beyer@dzne.de

Prof. Dr. Joachim Schultze
LIMES-Institute
University of Bonn
German Center for Neurodegenerative Diseasses (DZNE)
Tel. +49-228-7362787
E-mail: j.schultze@uni-bonn.de

University of Bonn

Related Immune System Articles:

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.
Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.
How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.
Immune system upgrade
Theoretically, our immune system could detect and kill cancer cells.
Using the immune system as a defence against cancer
Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence.
First impressions go a long way in the immune system
An algorithm that predicts the immune response to a pathogen could lead to early diagnosis for such diseases as tuberculosis
Filming how our immune system kill bacteria
To kill bacteria in the blood, our immune system relies on nanomachines that can open deadly holes in their targets.
Putting the break on our immune system's response
Researchers have discovered how a tiny molecule known as miR-132 acts as a 'handbrake' on our immune system -- helping us fight infection.
Decoding the human immune system
For the first time ever, researchers are comprehensively sequencing the human immune system, which is billions of times larger than the human genome.
Masterswitch discovered in body's immune system
Scientists have discovered a critical part of the body's immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.
More Immune System News and Immune System Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.